Funds and ETFs Healius Limited

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:47 2024-05-10 am EDT 5-day change 1st Jan Change
1.25 AUD +1.63% Intraday chart for Healius Limited +8.70% -23.55%

ETFs positioned on Healius Limited

Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
1.25 AUD
Average target price
1.364 AUD
Spread / Average Target
+9.13%
Consensus
  1. Stock Market
  2. Equities
  3. HLS Stock
  4. Funds and ETFs Healius Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW